US support of AIDS patent pool puts pressure on big pharma
This article was originally published in Scrip
Executive Summary
The US government's primary agency for medical research funding, the NIH, has licensed its patents for the HIV drug, darunavir, to the AIDS medicine patent pool, marking the first organisation to do so.